ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complicated Cases Discussed in Pediatric Thieves Market

Thomas R. Collins  |  Issue: December 2025  |  November 14, 2025

CHICAGO—A slate of pediatric rheumatologists recounted a series of interesting cases, ranging from a teenage track athlete with mysterious fatigue to a young adult with worsening headache, memory changes and a complex medical history, in ACR Convergence 2025’s Pediatric Thieves Market, in which the audience decided which case was most compelling.

All of the cases involved a winding road to diagnosis and left clinicians with important lessons to share in their presentations.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

15-Year-Old Track Star

Drayton Harvey, PhD, a fourth-year medical student in the MD-PhD program at the University of Southern California, Los Angeles, and the California Institute of Technology, Pasadena, discussed the case of a 15-year-old track star who could run a 5.5-minute mile in the 1600-meter race. At a track meet, he’d only been able to jog and had been exhausted by the end. It was later learned he’d been having trouble keeping up with his family on a ski trip a few months earlier.

He was found to have a creatine kinase of 30,000 u/L (reference range: 10–205 u/L) and was hospitalized, then discharged after a week with a rhabdomyolysis diagnosis. But he was soon hospitalized again with worsening weakness. On a neuromuscular test, he was found to have mostly normal strength but was hyperreflexic. He had a positive Gower sign, a sign of weakness in the hips and thighs. A genetic panel was unremarkable, and he was sent home to rest and get additional work up as an outpatient.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

After being unable to tie his shoes or get through a half day of school, he was hospitalized again. An expanded myositis panel was sent out, he was found to have oropharyngeal dysphagia that he was able to clear with throat clearing.

After a five-day steroid pulse, he regained strength and consistently met his occupational and physical therapy goals.

The results of the muscle biopsy showed scattered degenerating and regenerating fibers and few lymphocytes or spare macrophages on hematoxylin and eosin (H&E) staining; MHC-1 staining showed patchy sarcolemmal positivity; and he had positive LC3 staining.

The diagnosis was a rare case of immune-mediated necrotizing myositis (IMNM). Dr. Harvey said part of what made the case vexing was the lack of cutaneous abnormalities, which are often seen in IMNM. He said IMNM can get confused with limb girdle muscular dystrophy (MD) because MD can present in such a heterogeneous way.

“Most importantly,” Dr. Harvey said, “we sent an expanded myositis panel and that is about the only way for us to get antibody positivity in these cases. It’s not on your traditional, more narrow myositis panel.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025case reportpatient carepediatric conditions

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences